Variations in sensitivity to ionizing radiation in relation to p53 mutation point

Anticancer Research

Volumn 28, Issue 5 A, 2008, Pages 2687-2690

  Okaichi, Kumio ^a   Ide Kanematsu, Miwa ^a   Izumi, Nanaka ^a   Morita, Naoko ^a   Okumura, Yutaka ^a   Ihara, Makoto ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Ionizing radiation; Mutant p53; Radiosensitivity; Saos 2

Indexed keywords

PROTEIN P53;

ARTICLE; CODON; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; IONIZING RADIATION; POINT MUTATION; PRIORITY JOURNAL; RADIOSENSITIVITY; SENSITIVITY ANALYSIS;

BONE NEOPLASMS; CELL LINE, TUMOR; GENES, P53; HUMANS; MUTAGENESIS; NEOPLASMS; OSTEOSARCOMA; POINT MUTATION; RADIATION TOLERANCE; TRANSFORMATION, GENETIC;

EID: 55749115264     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
2. Mercer WE, Shields MT, Amin M, Sauve GJ, Appella E, Romano JW and Ullrich SJ: Negative growth regulation in a glioblastoma tumour cell line that conditionally expresses human wild-type p53. Proc Nat Acad Sci USA 87: 6166-6170, 1990.
3. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849, 1993.
4. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Davilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC and Vogelstein B: Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708, 1989.
5. Lee JM and Bernstein A: p53 mutations increase resistance to ionizing radiation. Proc Nat Acad Sci USA 90: 5742-5746, 1993.
6. Hamada M, Fujiwara T, Hizuta A, Gochi A, Naomoto Y, Takakura N, Takahashi K, Roth JA, Tanaka N and Orita K: The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers. J Cancer Res Clin 122: 360-365, 1996.
7. Hinata N, Shirakawa T, Zhang Z, Matsumoto A, Fujisawa M, Okada H, Kamidono S and Gotoh A: Radiation induces p53-dependent cell apoptosis in bladder cancer cells with wild-type-p53 but not in p53-mutated bladder cancer cells. Urol Res 31: 387-396, 2003.
8. Böhnke A, Westphal F, Schmidt A, El-Awady RA and Dahm-Daphi J: Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cells. Int J Radiat Biol 80: 53-63, 2004.
9. Biard DS, Martin M, Rhun YL, Duthu A, Lefaix JL, May E and May P: Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development. Cancer Res 54: 3361-3364, 1994.
10. Bergqvist M, Brattström D, Gullbo J, Hesselius P, Brodin O and Wagenius G: p53 status and its in vitro relationship to radiosensitivity and chemosensitivity in lung cancer. Anticancer Res 23: 1207-1212, 2003.
11. Viktorsson K, Petris LD and Lewensohn R: The role of p53 in treatment responses of lung cancer. Biochem Biophys Res Commun 331: 868-880, 2005.
12. Okaichi K, Wang L, Ihara M and Okumura Y: Sensitivity to ionizing radiation in Saos-2 cells transfected with mutant p53 genes depends on the mutation position. J Radiat Res 39: 111-118, 1998.
13. Chen C and Okayama H: High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cellular Biol 7: 2745-2752, 1987.
14. Waf-1/Cip1/Sdi1 expression in response to ionizing radiation in a human osteosarcoma cell line, Saos-2. Int J Radiat Oncol Biol Phys 45: 975-980, 1999.
15. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC and Hainaut P: The IARC TP53 database: New online mutation analysis and recommendation to users. Human Mutation 19: 607-614, 2002.
16. Lane DP: p53, Guardian of the genome. Nature 358: 15-16, 1992.
17. Lane DP: A death in the life of p53. Nature 362: 786-787, 1993.
18. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sφrlie T, Hovig E, Smith-Sφrensen B, Montesano R and Harris CC: Database of p53 gene somatic mutations in human tumours and cell lines. Nucleic Acid Res 22: 3551-3555, 1994.
19. Hainaut P: The tumour suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival. Current Science 7: 76-82, 1995.
20. Song H, Hollistein M and Xu Y: p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Nature Cell Biol 9: 573-580, 2007.
21. May P and May E: Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18: 7621-7636, 1999.
22. Finlay CA, Hinds PW and Levine AJ: The p53 proto-oncogene can act as a suppressor of transformation. Cell 57: 1083-1093, 1989.
23. Baker SJ, Markowitz S, Fearon ER, Willson JK and Vogelstein B: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912-915, 1990.
24. Christophorou MA, Rungshausen I, Finch AJ, Swigart LB and Evan GJ: The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 443: 214-27, 2006.
25. Wang L, Okaichi K, Ihara M and Okumura Y: Sensitivity of anticancer drugs in Saos-2 cells transfected with mutant p53 varied with mutation point. Anticancer Res 18: 321-326, 1998.